Epigenetic activation of the TUSC3 gene as a potential therapy for XMEN disease

表观遗传学 免疫学 生物 癸他滨 免疫系统 癌症研究 基因表达 DNA甲基化 遗传学 基因
作者
Haodong Ding,Yuwei Li,Maoxin Fang,Jiaojiao Chen,Liu Li-pin,Zhigang Lu,Jia Hou,Min Luo
出处
期刊:The Journal of Allergy and Clinical Immunology [Elsevier BV]
卷期号:151 (6): 1622-1633.e10 被引量:4
标识
DOI:10.1016/j.jaci.2023.04.003
摘要

Background X-linked MAGT1 deficiency with increased susceptibility to Epstein-Barr virus infection and N-linked glycosylation defect (XMEN) disease is a rare combined immunodeficiency caused by loss-of-function mutations in the magnesium transporter 1 (MAGT1) gene. MAGT1 deficiency impairs magnesium transport and the N-linked glycosylation of a panel of proteins, which subsequently abolishes the expression of key immune receptors such as natural killer group 2, member D (aka NKG2D). These effects induce immune system abnormalities, chronic Epstein-Barr virus infection, and neoplasia. Recent research shows that MAGT1 and tumor candidate suppressor 3 (TUSC3) share high sequence and functional similarity. Objective We sought to investigate the feasibility of activating TUSC3 expression to provide a potential therapeutic strategy for XMEN disease. Methods The expression profiles of MAGT1 and TUSC3 were analyzed using multiple databases, real-time quantitative PCR, and Western blot. The effects of decitabine and panobinostat on the regulation of TUSC3 expression were explored in both MAGT1 knockout (KO)/patient-derived lymphocytes and MAGT1 KO hepatocytes. Results Although TUSC3 is widely expressed, it is undetectable specifically in the immune system and liver, consistent with the main diseased tissues in patients with XMEN disease. CRISPR/Cas9-mediated KO of MAGT1 in the NKL cell line successfully mimicked the phenotypes of XMEN patient–derived lymphocytes, and exogenous expression of TUSC3 rescued the deficiencies in KO NKL cells. Using this in vitro model, we identified 2 epigenetic drugs, decitabine and panobinostat, by screening. Combination treatment using these 2 drugs significantly upregulated TUSC3 expression and rescued the immune and liver abnormalities. Conclusions Epigenetic activation of TUSC3 expression constitutes an effective therapeutic strategy for XMEN disease. X-linked MAGT1 deficiency with increased susceptibility to Epstein-Barr virus infection and N-linked glycosylation defect (XMEN) disease is a rare combined immunodeficiency caused by loss-of-function mutations in the magnesium transporter 1 (MAGT1) gene. MAGT1 deficiency impairs magnesium transport and the N-linked glycosylation of a panel of proteins, which subsequently abolishes the expression of key immune receptors such as natural killer group 2, member D (aka NKG2D). These effects induce immune system abnormalities, chronic Epstein-Barr virus infection, and neoplasia. Recent research shows that MAGT1 and tumor candidate suppressor 3 (TUSC3) share high sequence and functional similarity. We sought to investigate the feasibility of activating TUSC3 expression to provide a potential therapeutic strategy for XMEN disease. The expression profiles of MAGT1 and TUSC3 were analyzed using multiple databases, real-time quantitative PCR, and Western blot. The effects of decitabine and panobinostat on the regulation of TUSC3 expression were explored in both MAGT1 knockout (KO)/patient-derived lymphocytes and MAGT1 KO hepatocytes. Although TUSC3 is widely expressed, it is undetectable specifically in the immune system and liver, consistent with the main diseased tissues in patients with XMEN disease. CRISPR/Cas9-mediated KO of MAGT1 in the NKL cell line successfully mimicked the phenotypes of XMEN patient–derived lymphocytes, and exogenous expression of TUSC3 rescued the deficiencies in KO NKL cells. Using this in vitro model, we identified 2 epigenetic drugs, decitabine and panobinostat, by screening. Combination treatment using these 2 drugs significantly upregulated TUSC3 expression and rescued the immune and liver abnormalities. Epigenetic activation of TUSC3 expression constitutes an effective therapeutic strategy for XMEN disease.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
SYLH应助小熊采纳,获得10
刚刚
妹妹发布了新的文献求助10
刚刚
刚刚
赘婿应助我必定发nature采纳,获得20
1秒前
Ava应助kofbird采纳,获得50
2秒前
zz完成签到,获得积分10
2秒前
星辰大海应助ybwei2008_163采纳,获得10
2秒前
4秒前
4秒前
QJYKKK完成签到,获得积分10
4秒前
composite66完成签到,获得积分10
4秒前
ccchao发布了新的文献求助30
5秒前
充电宝应助十三采纳,获得10
5秒前
大个应助橙橙橙采纳,获得10
5秒前
Dandanhuang完成签到,获得积分10
5秒前
FashionBoy应助孟孟采纳,获得30
7秒前
畅快的刚完成签到,获得积分10
9秒前
9秒前
xxxx完成签到,获得积分10
9秒前
vain发布了新的文献求助10
9秒前
李健应助芒果小鹌鹑采纳,获得10
9秒前
cc完成签到,获得积分10
10秒前
这个名字是不是独一无二完成签到,获得积分10
10秒前
颗粒完成签到,获得积分10
11秒前
11秒前
javeeen完成签到,获得积分10
12秒前
应俊完成签到 ,获得积分10
12秒前
1234完成签到 ,获得积分10
13秒前
轻松元柏完成签到,获得积分10
14秒前
WN发布了新的文献求助10
14秒前
14秒前
我必定发nature给我必定发nature的求助进行了留言
15秒前
组织因子发布了新的文献求助10
15秒前
16秒前
Sadgenius完成签到,获得积分10
18秒前
领导范儿应助妹妹采纳,获得10
19秒前
炒栗子发布了新的文献求助10
19秒前
llu关注了科研通微信公众号
20秒前
ly完成签到,获得积分10
21秒前
逍遥完成签到 ,获得积分20
22秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038569
求助须知:如何正确求助?哪些是违规求助? 3576279
关于积分的说明 11374944
捐赠科研通 3305979
什么是DOI,文献DOI怎么找? 1819354
邀请新用户注册赠送积分活动 892698
科研通“疑难数据库(出版商)”最低求助积分说明 815048